The Traderszone Network

Published in TZ Latest News 8 March, 2015 by The TZ Newswire Staff

Biotech Bubble Reaches Epic Proportions As Short Interest Rises

In January we noted that despite Janet Yellen’s “irrational exuberance” moment when, last summer, the Fed chair mentioned biotech as a sector where valuations looked “substantially stretched,” biotech stocks have continued their relentless ascent thanks in part to M&A deals worth 40 times sales and IPOs for pre-revenue companies. 

Now, with the sector still making new highs, the bubble chorus is getting louder. 

read more